Skip to main content
High RiskFDAfda-F-1065-2015OTHER

Fruitful Juice Product Bloody Mary Premium, Beverage Concentrate; Contains 54% Juice; 2 + 1 packed in 3 gal Bag in Box. UPC - 7 0073...

Category
Units Affected
174
Recall Date
January 15, 2015
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1065-2015.

Firm discovered that Worcestershire sauce used in making various drink mixes contains anchovies which were not declared on the ingredient label or Allergan information.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1065-2015.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Damon Industries or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1065-2015.

Damon Industries

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Damon Industries Recall FAQ

Damon Industries is the subject of a beverages safety report: Fruitful Juice Product Bloody Mary Premium, Beverage Concentrate; Contains 54% Juice; 2 + 1 packed in 3 gal Bag in Box. UPC - 7 0073.... The notice was published on January 15, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 174 units are potentially affected.